PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
12-Dec-2022 Utrogestan 100mg (micronised progesterone) capsules accepted by SMC for use as HRT in Scotland Besins Healthcare UK
12-Dec-2022 FORXIGA (dapagliflozin) APPROVED IN GREAT BRITAIN FOR SYMPTOMATIC CHRONIC HEART FAILURE ACROSS THE FULL SPECTRUM OF LEFT VENTRICULAR EJECTION FRACTION AstraZeneca
12-Dec-2022 POLB 001 LPS human challenge clinical trial successfully completed No serious adverse events reported Poolbeg Pharma plc
12-Dec-2022 New Clinical Data For Zanidatamab In HER2+ /HR+ Metastatic Breast Cancer Presented Today At 2022 SABCS Zymeworks Inc.
12-Dec-2022 Evolva statement to SER communication Evolva Holding SA
11-Dec-2022 MorphoSys Presents New Longer-term Phase 2 Results on Pelabresib in Myelofibrosis, Including Potential Disease-Modifying Activity, at ASH 2022  MorphoSys AG
10-Dec-2022 MorphoSys Presents Updated Tafasitamab Results in Newly Diagnosed DLBCL Patients from Final firstMIND Analysis at ASH 2022 MorphoSys AG
09-Dec-2022 Polymer protection for vaccines and drugs Science and Technology of Advanced Materials
09-Dec-2022 Pistoia Alliance Expands Diversity & Inclusion Leadership Program to Offer Rare Cross-Industry Collaboration Opportunity and Encourage Industry Transformation Pistoia Alliance
09-Dec-2022 Weekly Pharma & Life Science News Round-Up: 5th – 9th December 2022 PharmiWeb.Jobs
09-Dec-2022 Camizestrant significantly delayed disease progression in advanced ER-positive breast cancer, adding at least 3.5 months benefit versus FASLODEX® (fulvestrant) AstraZeneca
09-Dec-2022 Capivasertib plus FASLODEX® (fulvestrant) reduced the risk of disease progression or death by 40% versus FASLODEX in advanced HR-positive breast cancer AstraZeneca
09-Dec-2022 Immutep successfully achieves commercial scale in manufacturing of Eftilagimod Alpha Immutep
09-Dec-2022 Autolus announces pricing of public offering Syncona Ltd
08-Dec-2022 Douglas GmbH: Post-Closing Reorganization completed Douglas GmbH
08-Dec-2022 Emmes Launches Cell and Gene Therapy Center Emmes
08-Dec-2022 Laevoroc Oncology Announces Publication Identifying Purine Nucleoside Phosphorylase (PNP) as a Novel Metabolic Immune Checkpoint Laevoroc Oncology
08-Dec-2022 Sosei Heptares Enters R&D Agreements with the University of Oxford and KU Leuven to Identify and Validate Key GPCRs Driving Gastrointestinal and Immune Disorders Sosei Heptares
08-Dec-2022 Alliance Pharma Opens State-of- the-Art Bioanalytical Laboratory in Brisbane Alliance Pharma
08-Dec-2022 Dante Genomics launches doctor ordered, clinical whole genome sequencing in the U.S. in partnership with 1health.io Dante Genomics